Technology News and Research

RSS

New book from Fraser Institute discusses the government-run health insurance in Canada

As Americans debate the merits of a “public option” for health insurance, a new book published by the Fraser Institute, one of Canada’s leading economic think tanks, documents the many significant problems with government-run health care in Canada, providing valuable comparative information for U.S. policy-makers at a crucial moment.

8 Oct 2009

Doctors, hospitals lag on EMR but use props - new and old - to close gap

Electronic medical records could improve how care is delivered and financed, but too few doctors and hospitals use it now, Health and Human Services Secretary Kathleen Sebelius told attendees at the Cerner Health Conference in Kansas City Tuesday, the Kansas City Star reports.

8 Oct 2009

NIH grants over $3.8 million to Asuragen

Asuragen, Inc. announced today that it has received over $3.8 million in new grant funding for 2009 from the Small Business Innovative Research (SBIR), Small Business Technology Transfer (STTR), and American Recovery and Reinvestment Act (ARRA) funded initiatives of the National Institutes of Health (NIH) to further its development of molecular diagnostics for oncology and genetic disease.

8 Oct 2009

NIH funds Triple Ring Technologies' X-ray imaging system development

Triple Ring Technologies, Inc., a leading provider of early-stage advanced research and development services, today announced that it has been awarded a Challenge Grant from the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), as part of the American Recovery and Reinvestment Act (ARRA).

8 Oct 2009

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

Amarillo Biosciences, Inc. today announced that it has agreed to a strategic partnership with Intas Pharmaceuticals Limited (Intas), one of the top 20 pharmaceutical companies in India, whereby Intas will sponsor clinical trials of ABI's orally administered interferon-alpha lozenges in order to combat influenza. Intas will pay ABI a royalty on net sales after marketing approval is obtained in India.

8 Oct 2009

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Peregrine Pharmaceuticals, Inc. today announced that it has established a new Anti-Viral Research Group in its R&D organization.

7 Oct 2009

Webmedx releases its latest physician documentation technology and service platform

Webmedx, the fourth largest medical transcription service provider in the U.S. and the only leading company to employ a 100% domestic workforce, today announced the release of their latest physician documentation technology and service platform, Enterprise5. Sean Carroll, company CEO, announced the availability of Enterprise5 to a select group of customers and guests during a private reception at the American Health Information Management Association's 81st Annual Convention and Exhibition in Grapevine, Texas.

7 Oct 2009

Odyssey Thera to receive milestone payments from Pfizer

Odyssey Thera, Inc. announced that it will receive milestone payments from one of its investors, Pfizer Inc. following Pfizer's decision to progress drug candidates studied by Odyssey Thera as part of Odyssey's multi-year alliance with Pfizer announced in August, 2006.

7 Oct 2009

LiveData awarded a SBIR grant for integrating medical technologies

LiveData, Inc., a leader in real-time data integration and display, has been awarded a Phase II Small Business Innovation Research grant from the U.S. Army Telemedicine and Advanced Technology Research Center (TATRC). LiveData will use the $730,000 grant to develop an integrated clinical environment with CIMIT’s Medical Device Plug-and-Play (MD PnP) team.

7 Oct 2009

NCI awards BioMarker Strategies a SBIR contract to develop its SnapPath live-tumor-cell testing system

BioMarker Strategies, LLC announced today that it has been awarded a Fast-Track Small Business Innovation Research (SBIR) contract from the National Cancer Institute to develop the SnapPath™ live-tumor-cell testing system. BioMarker Strategies is developing the SnapPath™ system to enable oncologists to determine the most effective drug treatment for their cancer patients.

7 Oct 2009

Diabetech and Cinterion Wireless Modules announce their collaboration on fourth generation GlucoMON platform

Cinterion Wireless Modules, the global leader in cellular machine-to-machine (M2M) communication modules, and Diabetech, the leader in patient-centric health care programs, today announced their collaboration on the fourth generation GlucoMON® platform, the world’s easiest-to-use wireless diabetes management system designed to help the over 220 million people worldwide struggling to manage the global diabetes and pre-diabetes pandemic.

7 Oct 2009

Tranziger forms global advisory and business team to execute strategic transactions

Tranziger Limited announced today the formation of its global advisory and business team to advise and assess companies in the life sciences and healthcare sectors to execute strategic transactions and realise and optimise value from their portfolios in these turbulent times. Tranziger Limited is headquartered in London, England, UK and has offices in Washington, DC and Edinburgh.

7 Oct 2009

Roche and Genentech obtain license to use SurModics’ drug delivery system

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has signed a License and Development Agreement with Roche and Genentech, Inc., a wholly-owned member of the Roche Group.

7 Oct 2009

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Cleveland Clinic's Top 10 Medical Innovations for 2010 list features a wide range of new techniques and therapies that are being developed to treat everything from deafness and Parkinson's disease to pneumonia and sleep disorders.

7 Oct 2009

Baxter receives marketing authorization for CELVAPAN H1N1 pandemic influenza vaccine

Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.

From Baxter International Inc. 7 Oct 2009

Deputy Secretary Gould talks about strategies to implement President's reform agenda

Deputy Secretary of Veterans Affairs W. Scott Gould told federal government managers at an "Excellence in Government" conference today that translating the skills of political campaigning into governance is a major challenge many newly appointed agency leaders face in implementing the President's reform agenda.

7 Oct 2009

Transenterix raises $55 million to manufacture and market its revolutionary laparoscopic surgical platform

TransEnterix Inc. has secured $55 million in a second round of institutional financing, paving the way for the company to manufacture and market its revolutionary laparoscopic surgical platform.

7 Oct 2009

Tronics receives 2009 Foundry of the Year Award

Tronics, a leading global integrated manufacturer of custom MEMS, has received the 2009 Foundry of the Year Award from EuroAsia semiconductor magazine for its history of profitability and growth, including expanding its capabilities and markets by forming a global group of companies in 2008, during the worldwide economic downturn.

7 Oct 2009

German research institutes and companies to introduce their activities at WEFTEC.09

As part of the initiative "Research in Germany - Land of Ideas", German research institutes, universities and companies will introduce themselves and their activities at this year's WEFTEC.09.

7 Oct 2009

Patients and surgeons drive demand for elective orthopedic procedures despite economic slowdown

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, patients and surgeons are driving demand for elective orthopedic procedures.

7 Oct 2009

Technology News and Research

New book from Fraser Institute discusses the government-run health insurance in Canada

Doctors, hospitals lag on EMR but use props - new and old - to close gap

NIH grants over $3.8 million to Asuragen

NIH funds Triple Ring Technologies' X-ray imaging system development

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Webmedx releases its latest physician documentation technology and service platform

Odyssey Thera to receive milestone payments from Pfizer

LiveData awarded a SBIR grant for integrating medical technologies

NCI awards BioMarker Strategies a SBIR contract to develop its SnapPath live-tumor-cell testing system

Diabetech and Cinterion Wireless Modules announce their collaboration on fourth generation GlucoMON platform

Tranziger forms global advisory and business team to execute strategic transactions

Roche and Genentech obtain license to use SurModics’ drug delivery system

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Baxter receives marketing authorization for CELVAPAN H1N1 pandemic influenza vaccine

Deputy Secretary Gould talks about strategies to implement President's reform agenda

Transenterix raises $55 million to manufacture and market its revolutionary laparoscopic surgical platform

Tronics receives 2009 Foundry of the Year Award

German research institutes and companies to introduce their activities at WEFTEC.09

Patients and surgeons drive demand for elective orthopedic procedures despite economic slowdown

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News